Evaluation of graphene-derived bone scaffold exposure to the calvarial bone_in-vitro and in-vivo studies. Issue 1 (2nd January 2022)

• Record Type: Journal Article
• Authors: Lu, Yung-Chang; Chang, Ting-Kuo; Yeh, Shu-Ting; Lin, Tzu-Chiao; Lin, Hung-Shih; Chen, Chun-Hung; Huang, Chun-Hsiung; Huang, Chang-Hung
• Is Part Of: Nanotoxicology. Volume 16:Issue 1(2022)
• Page Start: 1
• Page End: 15
• Publication Date: 2022-01-02
• Subjects: Graphene -- nanomaterials -- bone scaffold -- biosafety -- biological response; Toxicology -- Periodicals; 615.9
• DOI: 10.1080/17435390.2022.2027036
• Languages: English
• ISSNs: 1743-5390

Abstract

Abstract: Graphene is a novel material which has recently been gaining great interest in the biomedical fields. Our previous study observed that graphene-derived particles help induce bone formation in a murine calvarial model. Here, we further developed a blended graphene-contained polycaprolactone (PCL/G) filament for application in a 3D-printed bone scaffold. Since implants are expected to be for long-term usage, in vitro cell culture and in vivo scaffold implants were evaluated in a critical-size bone defect calvarial model for over 60 weeks. Graphene greatly improved the mechanical strength by 30.2% compared to pure PCL. The fabricated PCL/G scaffolds also showed fine cell viability. In animal model, an abnormal electroencephalogram power spectrum and early signs of aging, such as hair graying and hair loss, were found in the group with a PCL/G scaffold compared to pure PCL scaffold. Neither of the abnormal symptoms caused death of all animals in both groups. The long-term use of graphene-derived biomaterials for in-vivo implants seems to be safe. But the comprehensive biosafety still needs further evaluation.